Financial Statements

Bio-Techne Corporation (TECH)


-6.14 (-1.68%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands

Retained Earning Schedule

Year 2021 2020 2019 2018 2017
Retained Earnings (Previous Year) 1,057932877799-
Net Income 1402299612676
Stock Dividends -63-557-0770
Dividend Paid -50-49-48-48-47
Retained Earnings 1,0851,057932877799

PPE Schedule

Year 2021 2020 2019 2018 2017
Gross PPE 248154145135-
Annual Depreciation 781463431150
Capital Expenditure -44-52-25-21-15
Net PPE 282248154145135

Intangible and Goodwill Schedule

Year 2021 2020 2019 2018 2017
Intangible and Goodwill (Previous Year) -579598733728
New Purchases -3-9-43-70-40
Intangible and Goodwill 579598733728843

Bio-Techne Corporation income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Bio-Techne Corporation FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.